Work

Pretargeted α Emitting Radioimmunotherapy Using 213Bi 1,4,7,10-Tetraazacyclododecane-N,N′,N″,N‴-Tetraacetic Acid-Biotin

Year: 2004

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-03-0171

Authors: Zhengsheng Yao, Meili Zhang, Kayhan Garmestani, Donald B. Axworthy, Robert W. Mallett, Alan R. Fritzberg, Lou J. Theodore, Paul S. Plascjak, William C. Eckelman, Thomas A. Waldmann, Ira Pastan, Chang H. Paik, Martin W. Brechbiel, Jorge A. Carrasquillo

Institutions: National Institutes of Health, National Institutes of Health Clinical Center, National Cancer Institute

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2102056877

FWCI: 4.269

Cites: 48

Cited by: 41

Related to: 10